250 related articles for article (PubMed ID: 31118277)
1. Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks.
Mallm JP; Iskar M; Ishaque N; Klett LC; Kugler SJ; Muino JM; Teif VB; Poos AM; Großmann S; Erdel F; Tavernari D; Koser SD; Schumacher S; Brors B; König R; Remondini D; Vingron M; Stilgenbauer S; Lichter P; Zapatka M; Mertens D; Rippe K
Mol Syst Biol; 2019 May; 15(5):e8339. PubMed ID: 31118277
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
Huang D; Ovcharenko I
BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL.
Amin S; Walsh M; Wilson C; Parker AE; Oscier D; Willmore E; Mann D; Mann J
J Cell Mol Med; 2012 Sep; 16(9):2074-84. PubMed ID: 22151263
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia.
Chen SS; Raval A; Johnson AJ; Hertlein E; Liu TH; Jin VX; Sherman MH; Liu SJ; Dawson DW; Williams KE; Lanasa M; Liyanarachchi S; Lin TS; Marcucci G; Pekarsky Y; Davuluri R; Croce CM; Guttridge DC; Teitell MA; Byrd JC; Plass C
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13433-8. PubMed ID: 19666576
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
[TBL] [Abstract][Full Text] [Related]
7. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
[TBL] [Abstract][Full Text] [Related]
8. Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males.
Marteau JB; Rigaud O; Brugat T; Gault N; Vallat L; Kruhoffer M; Orntoft TF; Nguyen-Khac F; Chevillard S; Merle-Beral H; Delic J
BMC Med Genomics; 2010 Nov; 3():53. PubMed ID: 21062507
[TBL] [Abstract][Full Text] [Related]
9. Uncovering the DNA methylome in chronic lymphocytic leukemia.
Cahill N; Rosenquist R
Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
[TBL] [Abstract][Full Text] [Related]
10. Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.
Ott CJ; Federation AJ; Schwartz LS; Kasar S; Klitgaard JL; Lenci R; Li Q; Lawlor M; Fernandes SM; Souza A; Polaski D; Gadi D; Freedman ML; Brown JR; Bradner JE
Cancer Cell; 2018 Dec; 34(6):982-995.e7. PubMed ID: 30503705
[TBL] [Abstract][Full Text] [Related]
11. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk loci.
Yan H; Tian S; Kleinstern G; Wang Z; Lee JH; Boddicker NJ; Cerhan JR; Kay NE; Braggio E; Slager SL
Hum Mol Genet; 2020 Sep; 29(16):2761-2774. PubMed ID: 32744316
[TBL] [Abstract][Full Text] [Related]
13. Nucleosome repositioning in chronic lymphocytic leukemia.
Piroeva KV; McDonald C; Xanthopoulos C; Fox C; Clarkson CT; Mallm JP; Vainshtein Y; Ruje L; Klett LC; Stilgenbauer S; Mertens D; Kostareli E; Rippe K; Teif VB
Genome Res; 2023 Oct; 33(10):1649-1661. PubMed ID: 37699659
[TBL] [Abstract][Full Text] [Related]
14. Constitutive promoter occupancy by the MBF-1 activator and chromatin modification of the developmental regulated sea urchin alpha-H2A histone gene.
Di Caro V; Cavalieri V; Melfi R; Spinelli G
J Mol Biol; 2007 Feb; 365(5):1285-97. PubMed ID: 17134720
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
16. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics.
Speedy HE; Beekman R; Chapaprieta V; Orlando G; Law PJ; Martín-García D; Gutiérrez-Abril J; Catovsky D; Beà S; Clot G; Puiggròs M; Torrents D; Puente XS; Allan JM; López-Otín C; Campo E; Houlston RS; Martín-Subero JI
Nat Commun; 2019 Aug; 10(1):3615. PubMed ID: 31399598
[TBL] [Abstract][Full Text] [Related]
17. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
[TBL] [Abstract][Full Text] [Related]
18. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
19. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
[TBL] [Abstract][Full Text] [Related]
20. Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism.
Kandaswamy R; Sava GP; Speedy HE; Beà S; Martín-Subero JI; Studd JB; Migliorini G; Law PJ; Puente XS; Martín-García D; Salaverria I; Gutiérrez-Abril J; López-Otín C; Catovsky D; Allan JM; Campo E; Houlston RS
Cell Rep; 2016 Aug; 16(8):2061-2067. PubMed ID: 27524613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]